Click For Photo: https://cdn01.dailycaller.com/wp-content/uploads/2019/09/iaaf-track-e1569618246554.jpg
Biological males who identify as transgender women are likely to retain strength advantages over biological females, even after undergoing 12 months of hormone therapy, according to a new study out of Sweden.
The researchers who carried out the study found that biological males who underwent 12 months of hormone therapy lost muscle mass in their legs, but still retained leg strength.
Results - Months - Therapy - Transwoman - Performance
“Our results indicate that after 12 months of hormonal therapy, a transwoman will still likely have performance benefits over a cis-woman,” they concluded.
Researchers with the Karolinska Institute — a Swedish medical university — and Linkoping University, a state university in Sweden, carried out the study, which is awaiting the peer review process.
Study - Version - Thursday - Indication - Athletes
The study, a preprint version of which was posted online Thursday, is just the latest scientific indication that female athletes are at a disadvantage when forced to compete against males who identify as transgender women.
A paper published in the Journal of Medical Ethics in June found that male athletes who identify as transgender women have an “intolerable” advantage over their female competitors, even after suppressing testosterone levels.
Fair - Play - Women - Group - Inclusion
Fair Play For Women, a group opposing the inclusion of male athletes in female athletics, pointed to the new study as evidence that female athletes are unfairly disadvantaged by transgender athlete policies.
“Sports bodies where thigh muscle strength gives a clear advantage in competition must suspend their trans eligibility rules immediately,” the group said in a release on Friday, listing cycling,...
Wake Up To Breaking News!